Urgent.News

600+ sources. One page. See who else covered it.

Editions

Health & Medicine

FDA approves Bristol Myers’ multiple myeloma successor

The FDA has granted accelerated approval for a Bristol Myers Squibb pill called iberdomide for patients with multiple myeloma that’s returned or stopped responding to treatment. Iberdomide is marketed as Zenbexus, and carries a list ...

We haven't written up this one. Endpoints News has the full story — the link below goes straight to it.

Read the original at endpoints.news →

More in Health & Medicine